Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
Independence/ Ethnic day celebration at Valuebound
Valuebound celebrated 69th Pre-Independence Day Celebration cum Ethnic day with lots of fun wearing traditional dresses,decorating office in the spirit of Independence Day with tri colour balloons…
|
Configuring & Debugging XDebug with PHPStorm For Drupal 7 on Mac os X yosemite
I am running my machine with nginx & php 5.6, First make sure that you have already installed Xdebug. We can check this with php version command
$ php -v
If you see ‘Xdebug v’ that means…
Drupal in a day at Brindavan College of Engineering
Valuebound conducted ‘Drupal in a Day’ workshop at Brindavan College of Engineering on 11th Aug'2015. One day workshop comprised of one-hour awareness session
|
Free Training by Valuebound, Bangalore on Drupal Global Training Days
Bangalore Drupal User Group in collaboration with Valuebound & TIME Inc India will be conducting a free Drupal training on Global Drupal Training Day, Sat, 29th Aug.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
